IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma
Clinical trial NCT05327231 · COMPLETED
Trial details
- NCT number
- NCT05327231
- Sponsor
- InxMed (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2021-12-03
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.